Program, not a pill

dawn

Over 300 DEA licensed prescribers from across U.S. send letter to Congress opposing the Modernizing Opioid Treatment Access Act (MOTAA) (H.R. 1359/S. 644)

“I’m proud to join my fellow providers from across the country in signing this letter to Congress expressing our strong opposition to the MOTAA. Although we share the bill sponsors’ goal to expand access to treatment in order to end the opioid crisis, this legislation will do more harm than good,” said Benjamin Nordstrom, M.D., Ph.D., a …

Read moreOver 300 DEA licensed prescribers from across U.S. send letter to Congress opposing the Modernizing Opioid Treatment Access Act (MOTAA) (H.R. 1359/S. 644)

Program Not A Pill (PNAP) Members Applaud Positive Opioid Use Treatment Policy Changes in End of Year Spending Package

PNAP applauds Congress passing, and President Biden signing into law, the FY 2023 Omnibus Appropriations bill, which included important policy provisions that will dramatically expand access to treatment for patients with opioid use disorder (OUD), particularly those in rural and underserved areas. These provisions include eliminating the requirement that patients must prove a one-year history …

Read moreProgram Not A Pill (PNAP) Members Applaud Positive Opioid Use Treatment Policy Changes in End of Year Spending Package

PNAP Members Applaud SAMHSA’s Commitment to Evidence-Based Regulation Changes in the Recent Proposed Updates to Federal Rules to Expand Access to Treatment for Opioid Use Disorder

Advocates for Opioid Addiction Treatment (AOAT) and American Association for the Treatment of Opioid Dependence (AATOD)—organizations supporting PNAP—released the following statement in response to proposed updates to federal regulations of opioid treatment released on December 12, 2022 by the U.S. Department of Health and Human Services (HHS), through its Substance Abuse and Mental Health Services …

Read morePNAP Members Applaud SAMHSA’s Commitment to Evidence-Based Regulation Changes in the Recent Proposed Updates to Federal Rules to Expand Access to Treatment for Opioid Use Disorder